XSHG
600186
Market cap3.07bUSD
Oct 09, Last price
10.76CNY
1D
-6.11%
1Q
-1.47%
Jan 2017
109.34%
Name
Lotus Health Group Co
Chart & performance
P/E
62.40
P/S
5.59
EPS
0.17
Div yield, %
—
Shrs. gr., 5y
4.12%
Rev. gr., 5y
15.85%
Revenues
3.45b
+30.45%
Net income
309m
+52.59%
CFO
221m
-66.18%
Dividend
Jul 11, 20020.3897 CNY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Lotus Health Group Company, formerly known as Lotus Health Industry Holding Group Company, operates within China as a manufacturer and supplier of healthy food items and condiments. Its product range encompasses seasoning agents like monosodium glutamate (MSG) and chicken bouillon, various starches (including potato and corn-based varieties), and a selection of healthy oils, energy beverages, and nutritious snacks. The company also provides essential pantry staples such as flour, rice, and pasta. Established in 1983, Lotus Health Group maintains its headquarters in Xiangcheng, China.
Key people
Jiantong Xia
Chairman of the Board · since 2015
Haifeng Li
Vice President · since 2020
Mingliang Gu
Director · since 2010
Jianzhong Liu
Independent Director · since 2013
Independent Director · since 2010
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||